Back
Zevra Therapeutics Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
ZVRA
Zevra Therapeutics
Last Price:
8.07
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Zevra Therapeutics Stock Forecast
- Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 19.8% based on the past 9 years of stock performance.
- Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Zevra Therapeutics Stock Undervalued?
The current Zevra Therapeutics [ZVRA] share price is $7.83. The Score for ZVRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. - ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 19.8% based on the past 9 years of stock performance.
Zevra Therapeutics Stock Rating
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics overpriced?
- Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
8.44
52-Week Low:
3.89
Prediction Charts
Market Cap:
412M
Price in USD:
7.83
Volume:
1M
Beta:
1.83
Technical Analysis
SMA50:
6.92
SMA100:
5.81
SMA200:
5.74
52-Wk Change:
53.83%
Stock Predictions
-
Is Zevra Therapeutics stock public?
Yes, Zevra Therapeutics is a publicly traded company. -
What is the Zevra Therapeutics stock quote today?
The Zevra Therapeutics stock price is 7.83 USD today. -
How to buy Zevra Therapeutics stock online?
You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 7.32 | 7.39 | 7.69 | 7.24 |
| Aug-30 | 7.43 | 7.65 | 7.70 | 7.29 |
| Sep-3 | 7.65 | 7.30 | 7.84 | 7.13 |
| Sep-4 | 7.27 | 7.19 | 7.64 | 7.16 |
| Sep-5 | 7.21 | 7.23 | 7.34 | 7.05 |
| Sep-6 | 7.31 | 7.32 | 7.39 | 7.07 |
| Sep-9 | 7.32 | 7.25 | 7.60 | 7.16 |
| Sep-10 | 7.23 | 7.22 | 7.42 | 7.13 |
| Sep-11 | 7.22 | 7.40 | 7.42 | 7.12 |
| Sep-12 | 7.40 | 7.59 | 7.84 | 7.35 |
| Sep-13 | 7.60 | 7.85 | 8.12 | 7.59 |
| Sep-16 | 8.00 | 7.78 | 8.18 | 7.77 |
| Sep-17 | 7.80 | 7.53 | 8.00 | 7.42 |
| Sep-18 | 7.50 | 7.83 | 8.11 | 7.50 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.35 per share, and an increase next year of $1.14 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.